Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Bunse, Mario Dr. (1) Clauß, Julian (1) Ivics, Zoltan Dr. (1) Izsvak, Zsuzsanna Dr. (1) Kammertöns, Thomas Dr. (4) Kieback, Elisa Dr. (2) Leisegang, Matthias Prof. Dr. rer. nat. (3) Na, Il-Kang Dr. (1) Pezzutto, Antonio Prof. Dr. (3) Rehm, Armin Dr. (1) Schlag, Peter M. Prof. Dr. (1) Siffrin, Volker (1) Uckert, Wolfgang Prof. Dr. (6) Willimsky, Gerald Dr. (8) (-) Blankenstein, Thomas Prof. Dr. (23) (-) Daniel, Peter Prof. Dr. (1) (-) Höpken, Uta Elisabeth PD Dr. (1) (-) Kopp, Joachim Dr. (1) Advanced Light Microscopy (1) Biologie maligner Lymphome (13) Immundysregulationen in der Onkologie (1) Immunregulation und Krebs (2) Mikroumgebung als Regulator bei Autoimmunität und Krebs (9) (-) Molekulare Immunologie und Gentherapie (25) Proteom Dynamik (1) RNA Biologie und Posttranscriptionale Regulation (1) Strukturbiologie Membran-assoziierter Prozesse (1) Systembiologie von Gen-regulatorischen Elementen (5) Translationale Onkologie solider Tumore (1) Translationale Tumorimmunologie (2) Zellzustände und ihre Funktionsweisen (1) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) 1997 (9) 1998 (9) 1999 (2) (-) 2000 (8) 2001 (5) 2002 (5) 2003 (9) 2004 (8) 2005 (10) 2006 (1) 2007 (5) (-) 2008 (5) 2009 (2) 2010 (7) 2011 (5) 2012 (6) 2013 (11) (-) 2014 (3) (-) 2015 (4) 2016 (4) 2017 (6) (-) 2018 (5) 2019 (6) 2021 (4) 2022 (6) 2023 (4) 2024 (2) 25 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Daniel, Peter Prof. Dr.Höpken, Uta Elisabeth PD Dr.Kopp, Joachim Dr.Molekulare Immunologie und Gentherapie 20002008201420152018 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. Februar 2000 / Canc Res Interleukin-7/B7.1-encoding adenoviruses induce rejection of transplanted but not nontransplanted tumors G. Willimsky T. Blankenstein 01. Januar 2000 / Hum Gene Ther Efficient gene transfer into primary human CD8+ T lymphocytes by MuLV-10A1 retrovirus pseudotype W. Uckert C. Becker M. Gladow D. Klein T. Kammertoens L. Pedersen T. Blankenstein 01. Juni 2000 / Immunity CD4+ T cell-mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFNgamma receptor expression by nonhematopoietic cells Z.H. Qin T. Blankenstein 01. Mai 2000 / Bone Marrow Transplant Bcr/abl+ autologous dendritic cells for vaccination in chronic myeloid leukemia J. Westermann J. Kopp I. Koerner G. Richter Z. Qin T. Blankenstein B. Doerken A. Pezzutto 01. Mai 2000 / Bone Marrow Transplant Allogeneic vaccination for renal cell carcinoma: development and monitoring H. Pohla B. Frankenberger B. Stadlbauer R. Oberneder A. Hofstetter G. Willimsky A. Pezzutto B. Doerken T. Blankenstein D.J. Schendel 01. Oktober 2000 / Tissue Antigens Coordinate downregulation of multiple MHC class I antigen processing genes in chemical-induced murine tumor cell lines of distinct origin B. Seliger U. Wollscheid F. Momburg T. Blankenstein C. Huber 01. Dezember 2000 / Gene Ther Expression of B7.1 (CD80) in a renal cell carcinoma line allows expansion of tumor-associated cytotoxic T lymphocytes in the presence of an alloresponse D.J. Schendel B. Frankenberger P. Jantzer S. Cayeux E. Noessner G. Willimsky B. Maget H. Pohla T. Blankenstein 01. Januar 2000 / J Gene Med MLV-10A1 retrovirus pseudotype efficiently transduces primary human CD4+ T lymphocytes M. Gladow C. Becker T. Blankenstein W. Uckert 01. Oktober 2008 / Int J Cancer SV40 large T antigen-transformed human primary normal and cancerous mammary epithelial cells are phenotypically similar but can be distinguished in 3D culture with selection medium L.P. Li G. Willimsky S. Seitz Y. Xu Y. Li L.E. Schwarz P.M. Schlag T. Blankenstein 11. November 2008 / Proc Natl Acad Sci U S A Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas A. Kruschinski A. Moosmann I. Poschke H. Norell M. Chmielewski B. Seliger R. Kiessling T. Blankenstein H. Abken J. Charo Seitennummerierung Aktuelle Seite 1 Seite 2 Seite 3 Nächste Seite Next › Letzte Seite Last »
01. Februar 2000 / Canc Res Interleukin-7/B7.1-encoding adenoviruses induce rejection of transplanted but not nontransplanted tumors G. Willimsky T. Blankenstein
01. Januar 2000 / Hum Gene Ther Efficient gene transfer into primary human CD8+ T lymphocytes by MuLV-10A1 retrovirus pseudotype W. Uckert C. Becker M. Gladow D. Klein T. Kammertoens L. Pedersen T. Blankenstein
01. Juni 2000 / Immunity CD4+ T cell-mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFNgamma receptor expression by nonhematopoietic cells Z.H. Qin T. Blankenstein
01. Mai 2000 / Bone Marrow Transplant Bcr/abl+ autologous dendritic cells for vaccination in chronic myeloid leukemia J. Westermann J. Kopp I. Koerner G. Richter Z. Qin T. Blankenstein B. Doerken A. Pezzutto
01. Mai 2000 / Bone Marrow Transplant Allogeneic vaccination for renal cell carcinoma: development and monitoring H. Pohla B. Frankenberger B. Stadlbauer R. Oberneder A. Hofstetter G. Willimsky A. Pezzutto B. Doerken T. Blankenstein D.J. Schendel
01. Oktober 2000 / Tissue Antigens Coordinate downregulation of multiple MHC class I antigen processing genes in chemical-induced murine tumor cell lines of distinct origin B. Seliger U. Wollscheid F. Momburg T. Blankenstein C. Huber
01. Dezember 2000 / Gene Ther Expression of B7.1 (CD80) in a renal cell carcinoma line allows expansion of tumor-associated cytotoxic T lymphocytes in the presence of an alloresponse D.J. Schendel B. Frankenberger P. Jantzer S. Cayeux E. Noessner G. Willimsky B. Maget H. Pohla T. Blankenstein
01. Januar 2000 / J Gene Med MLV-10A1 retrovirus pseudotype efficiently transduces primary human CD4+ T lymphocytes M. Gladow C. Becker T. Blankenstein W. Uckert
01. Oktober 2008 / Int J Cancer SV40 large T antigen-transformed human primary normal and cancerous mammary epithelial cells are phenotypically similar but can be distinguished in 3D culture with selection medium L.P. Li G. Willimsky S. Seitz Y. Xu Y. Li L.E. Schwarz P.M. Schlag T. Blankenstein
11. November 2008 / Proc Natl Acad Sci U S A Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas A. Kruschinski A. Moosmann I. Poschke H. Norell M. Chmielewski B. Seliger R. Kiessling T. Blankenstein H. Abken J. Charo